- /
- Supported exchanges
- / US
- / MDT.NYSE
Medtronic PLC (MDT NYSE) stock market data APIs
Medtronic PLC Financial Data Overview
Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients in the United States, Ireland, and internationally. It operates through three segments: The Cardiovascular Portfolio, Neuroscience Portfolio, and Medical Surgical Portfolio. The Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac monitor systems; TYRX products; and remote monitoring and patient-centered software. It also provides aortic valves, surgical valve replacement and repair products, endovascular stent grafts and accessories, and transcatheter pulmonary valves, left atrial appendage exclusion systems, extracorporeal membrane oxygenation (ECMO) systems and percutaneous coronary intervention products, percutaneous angioplasty balloons, and endovenous products. The Neuroscience Portfolio segment offers medical devices and implants, biologic solutions, spinal cord stimulation and brain modulation systems, implantable drug infusion systems, and interventional products, as well as nerve ablation system under the Accurian name. This segment offers its products for spinal surgeons, neurosurgeons, neurologists, pain management specialists, anesthesiologists, orthopedic surgeons, urologists, urogynecologists, and interventional radiologists, as well as ear, nose, and throat specialists, and energy surgical instruments. The Medical Surgical Portfolio segment offers surgical stapling devices, vessel sealing instruments, wound closure and electrosurgery products, AI-powered surgical video and analytics platform, robotic-assisted surgery products, hernia mechanical devices, mesh implants, gynecology products, gastrointestinal and hepatologic diagnostics and therapies, and therapies to treat diseases and conditions, and patient monitoring and airway management products, as well as insulin pumps and consumables, continuous glucose monitoring sys
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
ETFs with Medtronic PLC (top by weight)
* We provide detailed information about ETF constituents through our Fundamentals API for ETFs. Read the documentation to learn more.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Or get access to advanced financial data starting only $19.99
Get Medtronic PLC data using free add-ons & libraries
Get Medtronic PLC Fundamental Data
Medtronic PLC Fundamental data includes:
- Net Revenue: 37 542 M
- EBITDA: 10 408 M
- Earnings Per Share: 4
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
End-of-day & Earnings data
What’s included:
- Latest Release: 2026-09-01
- EPS/Forecast: 1.39
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Medtronic PLC News
New
Medtronic Raises 2027 Outlook as Broad-Based Growth Gains Momentum
Medtronic plc MDT raised its fiscal 2027 outlook after first-quarter earnings and revenues exceeded expectations and growth accelerated across its major businesses. The stronger start gives management...
ISRG Stock Trading at its Cheapest in 10 Years: Should You Buy Now?
Intuitive Surgical ISRG is trading at its cheapest valuation in the last 10 years following a decline of more than 40% after touching the $600 level in January this year. Its forward 12-month P/E of 3...
Wall Street Isn't Talking About High-Yield Medtronic Stock -- Here's Why It Should Be
Medtronic (NYSE: MDT) is kind of a boring business. Sure, it is one of the world's largest medical device makers, but its diversified portfolio tends to mask the exciting developments taking place in ...
Jim Cramer says investors are too focused on AI stocks
CNBC's Jim Cramer said Tuesday that investors have grown too concentrated in artificial intelligence stocks and should look beyond the sector for opportunities over the next two months. "There's more...
Corporate Events Calendar & News package for
Or get access to advanced financial data starting only $19.99
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.